Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Eyetech Pharmaceuticals, Inc. (NASDAQ: EYET) today announced that the closing of the OSI acquisition...
Stockholders Overwhelmingly Approve Merger NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) provided an...
Company achieves operating profitability, excluding certain charges, based on total revenue of $67.4 million and net product revenue of $55.5...
Phase 2 study of Macugen in diabetic macular edema (DME) published in the October issue of Ophthalmology NEW YORK, Oct. 17...
Retrospective, subgroup analyses of the VISION study suggest that treatment of early disease with Macugen may further reduce the risk of vision...
NEW YORK, Sept. 16 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) announced today that the Committee for Medicinal...
Acquisition Projected to be Accretive and Generate Combined 2006 Revenues of Over $600 Million MELVILLE, N.Y. and NEW YORK, Aug. 21...
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Eyetech Pharmaceuticals, Inc. (NASDAQ: EYET) today announced that they have entered into a definitive...
Award recognizes Macugen's breakthrough technology as the first anti- angiogenic treatment approved in ophthalmology and the first aptamer therapy...
Eyetech Reports Second Quarter 2005 Financial Results - Gross Product Revenue for Macugen(R) (pegaptanib sodium injection) increased to $50...
Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal Specialists NEW YORK, July 18 /PRNewswire-FirstCall/ -- Research presented...
Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005 NEW YORK, July 15 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals...
Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection) Company shares research and development program to expand...
Eyetech Vision Day to Preview Future of Macugen Franchise Top Eyetech Executives and Ophthalmology Researchers to Present at Event This Wednesday...
Eyetech to Host Vision Day on Wednesday, June 22 Company to Comment On Macugen Launch and Research and Development Programs Aimed at Expanding the...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지